Bajaj Healthcare Ltd

Bajaj Healthcare | 539872

Market Closed

₹443.30

+₹0.00 (+-0.88%)

As on 19/11/25, 2:19 AM

Market Cap1,412.56 CR

Current Price₹443.3

High / Low₹745 / 361.05

PE Ratio---

Book Value₹---

Dividend Yield---

ROCE---

ROE10.61%

Face Value₹2.00

Current Vol.37,747

Average Vol.12,76,53,456

ISININE411U01027

PB Ratio---

Debt to Equity---

Net Profit Margin---

Operating Margin---

Stock cgart

Stock Performance

₹2,480₹2,490

₹2,500

Previous CloseToday's Open

₹1,800₹3,000

₹2,500

52W Low52W High

₹2,480Today's Open

₹2,490Previous Close

12,00,000Volume

₹1,80052W Low

₹3,00052W High

Ratios

📊

Consolidated data not available

Please try selecting a different data type

About Company

Incorporated in 1993, Maharashtra-based Bajaj Healthcare Limited is one of India's large scale and vertically integrated pharmaceutical manufacturer for quality-conscious customers
The Company is engaged in the manufacturing and exporting of Active Pharmaceutical Ingredient (APIs), Intermediates, Finished Dosage Forms & Nutraceuticals
Company commenced its operations in 1993 with a single unit at Tarapur
It became a public company in 2005 and listed its shares in the Indian stock exchanges in 2016
With Headquartered in Thane, Company has established 3 API plants in Gujarat and Maharashtra
It has 4 units for APIs/ intermediates and one unit for formulation, which are designed to meet the requirements of both advanced as well as emerging market opportunities
In 2008, the Company acquired Formulations plant at Manjusar, Vadodara and have converted it into WHO-GMP compliant facility
In 2013, it set up another API and Intermediate manufacturing plant at Panoli, Ankleshwar and acquired and set up an Intermediate Unit in Tarapur MIDC, near Mumbai in November, 2014
The Company launched the initial public offer of 18,17,600 equity shares of Rs 10 each by raising funds of Rs 30
89 Cr, comprising a fresh issue of 1,49,600 equity shares amounting to Rs 2

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

;

Technical Indicators

RSI44.12

SMA 20454.87

SMA 50455.41

SMA 100467.35

SMA 200533.84

SMA 10448.31

MACD_12_26_Days-5.04

EMA10Day448.22

EMA20Day453.03

EMA50Day459.01

MACD_12_26_9_Days-1.73

EMA100Day473.48

EMA200Day486.18

Pivot Points

Volume Analysis

Growth Rate

📊

No Information Available

Growth Rate information is not available at this time.

All figures in ₹ Crores

📊

No Information Available

No profit & lossdata available

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

26 Sept 2025

AGM

08 Sept 2025

19 Sept 2025

Final Dividend (₹1)

Recommended a Final Dividend of 20% i.e. Rs. 1.00/- per equity share on Face Value of Rs. 5/- each for the Financial Year 2024-25, subject to the approval of Shareholders of the Company at the ensuing Annual General Meeting of the Company.

26 May 2025

30 Sept 2024

AGM

17 Sept 2024

24 Sept 2024

Final Dividend (₹1)

Outcome of Board Meeting held on 24th May, 2024

24 May 2024

07 Aug 2024

EGM

10 Jul 2024

30 Sept 2023

AGM

08 Sept 2023

23 Sept 2023

Final Dividend (₹1)

Outcome of Board Meeting held on 30th May, 2023 & Submission of financial result. Recommended a final dividend of 20% i.e. Re.1.00/- per equity share for the financial year ended 31st March, 2023, subject to approval of shareholders in the ensuing Annual General Meeting. Intimation of record dates for payment of dividend. (As Per BSE Announcement dated on 07.09.2023)

30 May 2023

30 Sept 2022

AGM

14 Sept 2022

23 Sept 2022

Final Dividend (₹1.5)

We hereby inform you that at the meeting of the Board of Directors of our Company held today i.e. 17th May, 2022 has considered and approved the following: - The Board of Directors have recommended a final dividend of 30% i.e. Rs.1.50/- per equity shares on face value of Rs.5/- each for the financial year ended 31st March, 2022, subject to approval of shareholders in the ensuing Annual General Meeting. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Friday, September 23, 2022 is fixed as the record date for the purpose of payment of dividend, if approved by the shareholders at the ensuing Annual General Meeting. (As Per BSE Announcement Dated 08.09.2022)

17 May 2022

30 Sept 2021

AGM

08 Sept 2021

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
436			0
1,760	4,22,211	37	5	30	0	20.88%
6,475	1,71,898	69	11	59	0	23.41%
3,793	1,28,372	59	15	43	1	16.60%
1,515	1,22,349	22	4	19	0	19.21%
1,244	1,03,789	18	3	14	0	17.54%
2,047	93,506	22	5	17	0	14.56%
928	93,404	19	4	15	0	19.86%
2,224	91,800	53	6	35	0	14.39%
1,240	72,630	21	2	14	0	10.98%

Showing 10 of 125 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

Frequently Asked Questions

What is Share Price of Bajaj Healthcare Ltd?

The current share price of Bajaj Healthcare Ltd (Bajaj Healthcare) is ₹443.30. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the 52-week high and low of Bajaj Healthcare Ltd?

Bajaj Healthcare Ltd has a 52-week high of ₹745.00 and a 52-week low of ₹361.05. This range shows the stock's price volatility over the past year.

What is the ROE of Bajaj Healthcare Ltd?

Bajaj Healthcare Ltd has a Return on Equity (ROE) of 10.61%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds.